scorecardresearch
Saturday, May 4, 2024
Support Our Journalism
HomeIndiaCentre grants Bulk Drug Park to AP, to give Rs 1,000 cr...

Centre grants Bulk Drug Park to AP, to give Rs 1,000 cr aid

Follow Us :
Text Size:

Amaravati, Aug 30 (PTI) The Government of India has given in principle approval to Andhra Pradesh for setting up a Bulk Drug Park (BDP), with a grant-in-aid of Rs 1,000 crore, under the Promotion of Bulk Drug Parks scheme of the Department of Pharmaceuticals.

N Yuvaraj, Joint Secretary in the Union Department of Pharmaceuticals, has communicated this to the State government on Tuesday, asking it to convey its approval within seven days and, further, submit a Detailed Project Report within 90 days.

The Central grant is for creation of common infrastructure facilities in the BDP at the proposed location in Thondangi mandal in East Godavari district.

Andhra Pradesh is the only state from south India to bag the grant-in-aid for the BDP.

The State Cabinet had in August 2020 approved the setting up of the BDP in East Godavari district with an investment of Rs 6,940 crore, for which a special purpose vehicle called AP Bulk Drug Infrastructure Corporation was also constituted.

The State government will now have to scout for a private partner to develop the BDP at an extent of 2,000 acres.

While 13 States across the country competed for the BDP under the scheme, Gujarat, Himachal Pradesh and Andhra Pradesh finally emerged successful. PTI DBV KH SS SS

This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular